Peter D. Beitsch

15.9k total citations · 5 hit papers
114 papers, 9.4k citations indexed

About

Peter D. Beitsch is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Peter D. Beitsch has authored 114 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Cancer Research, 57 papers in Oncology and 41 papers in Pathology and Forensic Medicine. Recurrent topics in Peter D. Beitsch's work include Breast Cancer Treatment Studies (82 papers), Breast Lesions and Carcinomas (40 papers) and Breast Implant and Reconstruction (28 papers). Peter D. Beitsch is often cited by papers focused on Breast Cancer Treatment Studies (82 papers), Breast Lesions and Carcinomas (40 papers) and Breast Implant and Reconstruction (28 papers). Peter D. Beitsch collaborates with scholars based in United States, Switzerland and United Kingdom. Peter D. Beitsch's co-authors include Pat W. Whitworth, Kelly K. Hunt, Armando E. Giuliano, Peter Blumencranz, Linda McCall, A. Marilyn Leitch, Sukamal Saha, Karla V. Ballman, Monica Morrow and Frank A. Vicini and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Peter D. Beitsch

110 papers receiving 9.2k citations

Hit Papers

The Sentinel Node in Breast Cancer — A Multicenter Valida... 1998 2026 2007 2016 1998 2017 2010 2004 2007 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Sentinel Node in Breast Cancer — A Multicenter Validation Study
    1998 1.6k citations Peter D. Beitsch, Pat W. Whitworth et al. profile →
  2. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis
    2017 1.1k citations Armando E. Giuliano, Karla V. Ballman et al. profile →
  3. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases
    2010 879 citations Armando E. Giuliano, Linda McCall et al. Annals of Surgery profile →
  4. Circulating Tumor Cells in Patients with Breast Cancer Dormancy
    2004 778 citations Songdong Meng, Peter D. Beitsch et al. profile →
  5. Surgical Complications Associated With Sentinel Lymph Node Dissection (SLND) Plus Axillary Lymph Node Dissection Compared With SLND Alone in the American College of Surgeons Oncology Group Trial Z0011
    2007 660 citations Anthony Lucci, Linda McCall et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter D. Beitsch United States 43 7.0k 4.4k 4.1k 3.6k 891 114 9.4k
Mattia Intra Italy 53 8.4k 1.2× 5.4k 1.2× 3.9k 1.0× 4.1k 1.1× 1.2k 1.3× 160 10.7k
Stefano Zurrida Italy 52 9.4k 1.3× 6.9k 1.6× 5.3k 1.3× 5.2k 1.5× 1.1k 1.2× 181 13.8k
Marsha D. McNeese United States 55 6.7k 1.0× 4.4k 1.0× 4.0k 1.0× 3.1k 0.9× 1.2k 1.4× 131 9.4k
Pat W. Whitworth United States 33 5.4k 0.8× 3.8k 0.9× 2.6k 0.6× 3.0k 0.9× 590 0.7× 108 7.0k
Frederick C. Ames United States 55 5.8k 0.8× 3.7k 0.8× 3.7k 0.9× 3.2k 0.9× 959 1.1× 127 8.6k
Concetta De Cicco Italy 33 5.0k 0.7× 4.1k 0.9× 2.2k 0.5× 3.1k 0.9× 668 0.7× 66 7.3k
Barbara Silver United States 47 4.7k 0.7× 4.2k 1.0× 2.8k 0.7× 2.3k 0.6× 1.3k 1.4× 104 8.2k
Alain Fourquet France 62 9.5k 1.4× 5.6k 1.3× 5.5k 1.3× 2.6k 0.7× 1.8k 2.1× 374 14.0k
Renato A. Valdés Olmos Netherlands 56 2.6k 0.4× 1.7k 0.4× 2.5k 0.6× 3.2k 0.9× 1.9k 2.2× 224 8.7k
Neal S. Goldstein United States 52 2.7k 0.4× 2.6k 0.6× 2.9k 0.7× 2.6k 0.7× 2.1k 2.3× 164 7.9k

Countries citing papers authored by Peter D. Beitsch

Since Specialization
Citations

This map shows the geographic impact of Peter D. Beitsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter D. Beitsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter D. Beitsch more than expected).

Fields of papers citing papers by Peter D. Beitsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter D. Beitsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter D. Beitsch. The network helps show where Peter D. Beitsch may publish in the future.

Co-authorship network of co-authors of Peter D. Beitsch

This figure shows the co-authorship network connecting the top 25 collaborators of Peter D. Beitsch. A scholar is included among the top collaborators of Peter D. Beitsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter D. Beitsch. Peter D. Beitsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heald, Brandie, Sara Pirzadeh‐Miller, Rachel E. Ellsworth, et al.. (2023). Cascade testing for hereditary cancer: comprehensive multigene panels identify unexpected actionable findings in relatives. JNCI Journal of the National Cancer Institute. 116(2). 334–337. 3 indexed citations
2.
Groenendijk, Floris H., Paul L. Baron, Peter D. Beitsch, et al.. (2019). Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers. npj Breast Cancer. 5(1). 15–15. 16 indexed citations
3.
Alvarado, Michael, Elizabeth A. Mittendorf, Mediget Teshome, et al.. (2019). SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer. Annals of Surgical Oncology. 26(11). 3510–3516. 50 indexed citations
4.
Kwon, Mi, Sae Byul Lee, Jinil Han, et al.. (2018). BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer. PLoS ONE. 13(11). e0207155–e0207155. 10 indexed citations
5.
Beitsch, Peter D., Pat W. Whitworth, Paul L. Baron, et al.. (2017). Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST). Annals of Surgical Oncology. 24(9). 2539–2546. 28 indexed citations
6.
Beitsch, Peter D., et al.. (2016). Genomic Impact of Neoadjuvant Therapy on Breast Cancer: Incomplete Response is Associated with Altered Diagnostic Gene Signatures. Annals of Surgical Oncology. 23(10). 3317–3323. 11 indexed citations
7.
Giuliano, Armando E., Karla V. Ballman, Linda McCall, et al.. (2016). Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases. Annals of Surgery. 264(3). 413–420. 336 indexed citations
8.
Spector, Neil L., Faith C. Robertson, Sarah Bacus, et al.. (2015). Lapatinib Plasma and Tumor Concentrations and Effects on HER Receptor Phosphorylation in Tumor. PLoS ONE. 10(11). e0142845–e0142845. 21 indexed citations
9.
10.
Gainer, Sarah M., Kelly K. Hunt, Peter D. Beitsch, et al.. (2012). Changing Behavior in Clinical Practice in Response to the ACOSOG Z0011 Trial: A Survey of the American Society of Breast Surgeons. Annals of Surgical Oncology. 19(10). 3152–3158. 76 indexed citations
11.
Roses, Robert E., Henry M. Kuerer, Richard E. Fine, et al.. (2011). Axillary Failure in Patients Treated with MammoSite Accelerated Partial Breast Irradiation. Annals of Surgical Oncology. 18(12). 3415–3421. 11 indexed citations
12.
Beitsch, Peter D., et al.. (2010). Post-surgical treatment of early-stage breast cancer with electronic brachytherapy: an intersociety, multicenter brachytherapy trial. SHILAP Revista de lepidopterología. 1 indexed citations
13.
Shaitelman, Simona F., Frank A. Vicini, Peter D. Beitsch, et al.. (2010). Five‐year outcome of patients classified using the American Society for Radiation Oncology consensus statement guidelines for the application of accelerated partial breast irradiation. Cancer. 116(20). 4677–4685. 64 indexed citations
14.
Boughey, Judy C., Elizabeth A. Mittendorf, Lawrence J. Solin, et al.. (2010). Controversies in Breast Surgery. Annals of Surgical Oncology. 17(S3). 230–232. 9 indexed citations
15.
16.
Jeruss, Jacqueline S., Frank A. Vicini, Peter D. Beitsch, et al.. (2006). Initial Outcomes for Patients Treated on the American Society of Breast Surgeons MammoSite Clinical Trial for Ductal Carcinoma-In-Situ of the Breast. Annals of Surgical Oncology. 13(7). 967–976. 49 indexed citations
17.
Roberts, Cory A., Peter D. Beitsch, Craig E. Litz, et al.. (2003). Interpretive disparity among pathologists in breastsentinel lymph node evaluation. The American Journal of Surgery. 186(4). 324–329. 42 indexed citations
18.
Fehm, Tanja, Arthur I. Sagalowsky, Edward Clifford, et al.. (2002). Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.. PubMed. 8(7). 2073–84. 241 indexed citations
19.
Litz, Craig E., et al.. (2001). Intraoperative axillary sentinel lymph node touch imprints lack sensitivity in detecting metastatic breast carcinoma. Breast Cancer Research and Treatment. 69(3).
20.
Beitsch, Peter D.. (1994). Physical Examination and Arteriography in Patients With Penetrating Zone II Neck Wounds. Archives of Surgery. 129(6). 577–577. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mattia Intra Breakdown of academic impact, for papers by Stefano Zurrida Breakdown of academic impact, for papers by Marsha D. McNeese Breakdown of academic impact, for papers by Pat W. Whitworth Breakdown of academic impact, for papers by Frederick C. Ames Breakdown of academic impact, for papers by Concetta De Cicco Breakdown of academic impact, for papers by Barbara Silver Breakdown of academic impact, for papers by Alain Fourquet Breakdown of academic impact, for papers by Renato A. Valdés Olmos Breakdown of academic impact, for papers by Neal S. Goldstein
Rankless by CCL
2026